Seizure susceptibility alteration following reversible cholestasis in mice: Modulation by opioids and nitric oxide

European Journal of Pharmacology

Volumn 580, Issue 3, 2008, Pages 322-328

  Gholipour, Taha ^a,b   Riazi, Kiarash ^a   Noorian, Ali Reza ^a,b   Jannati, Ali ^a,b   Honar, Hooman ^a   Doratotaj, Behzad ^a   Nik, Hooman Hosseini ^a   Shariftabrizi, Ahmad ^a   Dehpour, Ahmad Reza ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alpha naphthylisothiocyanate; Cholestasis; Clonic seizure threshold; Morphine; Nitric oxide; Opioid; Pentylenetetrazole

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; BIOCHEMICAL MARKER; CORN OIL; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALTREXONE; NITRIC OXIDE; OPIATE; OPIATE RECEPTOR; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CHOLESTASIS; CLONIC SEIZURE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; ENZYME SYNTHESIS; MALE; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD;

1-NAPHTHYLISOTHIOCYANATE; ALKALINE PHOSPHATASE; ANIMALS; BILIRUBIN; BIOLOGICAL MARKERS; CHOLESTASIS; CORN OIL; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENOUS; INTUBATION, GASTROINTESTINAL; MALE; MICE; MORPHINE; NALTREXONE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTYLENETETRAZOLE; RECEPTORS, OPIOID; SEIZURES; TIME FACTORS;

EID: 38349120747     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.11.018     Document Type: Article

References (33)

1. Abboud G., and Kaplowitz N. Drug-induced liver injury. Drug Safety 30 (2007) 277-294
2. Bergasa N.V., Rothman R.B., Vergalla J., Xu H., Swain M.G., and Jones E.A. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J. Hepatol. 15 (1992) 220-224
3. Bergasa N.V., Alling D.W., Vergalla J., and Jones E.A. Cholestasis in the male rat is associated with naloxone-reversible antinociception. J. Hepatol. 20 (1994) 85-90
4. Chisholm J.W., Nation P., Dolphin P.J., and Agellon L.B. High plasma cholesterol in drug-induced cholestasis is associated with enhanced hepatic cholesterol synthesis. Am. J. Physiol. 276 (1999) G1165-G1173
5. Dehpour A.R., Akbarloo N., and Ghafourifar P. Endogenous nitric oxide modulates naloxone-precipitated withdrawal signs in a mouse model with acute cholestasis. Behav. Pharmacol. 9 (1998) 77-80
6. Fernandez-Martinez E., Perez-Alvarez V., Tsutsumi V., Shibayama M., and Muriel P. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat. Exp. Toxicol. Pathol. 58 (2006) 49-58
7. Frenk H. Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res. 287 (1983) 197-210
8. Frenk H., McCarty B.C., and Liebeskind J.C. Different brain areas mediate the analgesic and epileptic properties of enkephalin. Science 200 (1978) 335-337
9. Ghafourifar P., Dehpour A.R., and Akbarloo N. Inhibition by L-NA, a nitric oxide synthase inhibitor, of naloxone-precipitated withdrawal signs in a mouse model of cholestasis. Life. Sci. 60 (1997) PL 265-PL 270
10. Goodman Z.D., and Ishak K.G. Hepatic histopathology. In: Schiffer S.M., and Maddrey W.C. (Eds). Schiff Diseases of the Liver (2003), Lippincott Williams and Wilkins, Philadelphia 93-97
11. Homayoun H., Khavandgar S., Namiranian K., Gaskari S.A., and Dehpour A.R. The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice. Epilepsy Res. 48 (2002) 33-41
12. Homayoun H., Sayyah M., and Dehpour A.R. The additive effect of opioids and nitric oxide in increasing pentylenetetrazole-induced seizure threshold in cholestatic mice. J. Gastroenterol. Hepatol. 17 (2002) 96-101
13. Honar H., Riazi K., Homayoun H., Demehri S., Dehghani M., Vafaie K., Ebrahimkhani M.R., Rashidi N., Gaskari S.A., and Dehpour A.R. Lithium inhibits the modulatory effects of morphine on susceptibility to pentylenetetrazole-induced clonic seizure in mice: involvement of a nitric oxide pathway. Brain Res. 1029 (2004) 48-55
14. Khavandgar S., Homayoun H., and Dehpour A.R. The role of nitric oxide in the proconvulsant effect of delta-opioid agonist SNC80 in mice. Neurosci. Lett. 329 (2002) 237-239
15. Khavandgar S., Homayoun H., and Dehpour A.R. Mediation of nitric oxide in inhibitory effect of morphine against electroshock-induced convulsions in mice. Pharmacol. Biochem. Behav. 74 (2003) 795-801
16. Kolesnikov Y., Jain S., Wilson R., and Pasternak G.W. Blockade of morphine-induced hindlimb myoclonic seizures in mice by ketamine. Pharmacol. Biochem. Behav. 56 (1997) 423-425
17. Lauretti G.R., Ahmad I., and Pleuvry B.J. The activity of opioid analgesics in seizure models utilizing N-methyl-DL-aspartic acid, kainic acid, bicuculline and pentylenetetrazole. Neuropharmacology 33 (1994) 155-160
18. Loscher W., Honack D., Fassbender C.P., and Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res. 8 (1991) 171-189
19. Mandhane S.N., Aavula K., and Rajamannar T. Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice. Seizure 16 (2007) 636-644
20. Marie N., Aguila B., and Allouche S. Tracking the opioid receptors on the way of desensitization. Cell. Signal. 18 (2006) 1815-1833
21. Mombeini T., Roushanzamir F., Jorjani M., Pourpak Z., Gaskari S.A., Mehr S.E., and Dehpour A.R. Alteration in specific opioid-receptor labeling on peripheral blood leukocytes of bile duct-ligated rat. Pathophysiology 13 (2006) 111-117
22. Nidhi G., Balakrishnan S., and Pandhi P. Role of nitric oxide in electroshock and pentylenetetrazole seizure threshold in rats. Methods Find. Exp. Clin. Pharmacol. 21 (1999) 609-612
23. Osonoe K., Mori N., Suzuki K., and Osonoe M. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res. 663 (1994) 338-340
24. Riazi K., Honar H., Homayoun H., Rashidi N., Dehghani M., Sadeghipour H., Gaskari S.A., and Dehpour A.R. Sex and estrus cycle differences in the modulatory effects of morphine on seizure susceptibility in mice. Epilepsia 45 (2004) 1035-1042
25. Rodriguez-Garay E.A. Cholestasis: human disease and experimental animal models. Ann. Hepatol. 2 (2003) 150-158
26. Sagratella S., and Massotti M. Convulsant and anticonvulsant effects of opioids: relationship to GABA-mediated transmission. Neuropharmacology 21 (1982) 991-1000
27. Sherlock S., and Dooley J. Diseases of the Liver and Biliary System. 11 ed. (2002), Blackwell, Oxford
28. Starr M.S., and Starr B.S. Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacol. Biochem. Behav. 45 (1993) 321-325
29. Swain M.G., Rothman R.B., Xu H., Vergalla J., Bergasa N.V., and Jones E.A. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology 103 (1992) 630-635
30. Theard M.A., Baughman V.L., Wang Q., Pelligrino D.A., and Albrecht R.F. The role of nitric oxide in modulating brain activity and blood flow during seizure. Neuroreport 6 (1995) 921-924
31. Tortella F.C., and Cowan A. Studies on opioid peptides as endogenous anticonvulsants. Life Sci. 31 (1982) 2225-2228
32. Urca G., Frenk H., Liebeskind J.C., and Taylor A.N. Morphine and enkephalin: analgesic and epileptic properties. Science 197 (1977) 83-86
33. Wahler J.B., Swain M.G., Carson R., Bergasa N.V., and Jones E.A. Blood-brain barrier permeability is markedly decreased in cholestasis in the rat. Hepatology 17 (1993) 1103-1108